For Patients: Our Phase I trial is currently enrolling!
Multi-institutional team awarded NCI grant to open novel AML trial

For Patients: Our Phase I trial is currently enrolling!
Safety, Tolerability, and Preliminary Efficacy of JBZ-001 in Patients with Advanced Solid Tumors and Non-Hodgkin Lymphoma